Board Authorized Protocols 

On Wednesday, December 13, 2017 regulation 201 KAR 2:380. board authorized protocols was approved by the Health & Welfare & Family Services Interim Joint Committee. KPhA member, Representative Danny Bentley, PharmD, made the motion to approve the regulation.

“We started this discussion in March 2016, and with much collaborative effort, we have arrived at today’s outcome,” said KPhA Chair Trish Freeman. “It is a shining example of what can be accomplished when we all work together, united toward a common goal.”

The Kentucky Board of Pharmacy is now able to approve protocols as they are developed per the new regulation. We will link the approved protocols, once approved below. View the regulation from KBOP here.

Board authorized protocols may be established for the following conditions:
(1) Acute influenza infection pursuant to recommendations by the Centers for Disease Control and Prevention (CDC);
(2) Acute streptococcal pharyngitis infection;
(3) Acute, uncomplicated urinary tract infection;
(4) Acute mucocutaneous fungal infection;
(5) Allergic rhinitis;
(6) Anaphylaxis;
(7) HIV infection prevention through pre-exposure prophylaxis pursuant to recommendations by the CDC;
(8) Nutritional supplementation with multivitamins and minerals;
(9) Opioid use disorder pursuant to recommendations by the American Society of Addiction Medicine;
(10) Tobacco use disorder;
(11) Travelers health pursuant to recommendations by the CDC;
(12) Tuberculosis prevention and control through skin testing, and referral as necessary, pursuant to recommendations by the CDC; and
(13) Self-care conditions appropriately treated with over-the-counter medications and products.

Additional Resources 

Tobacco Use Disorder

Purdue University

Washington State Pharmacy Association (WSPA)

UCSF Schools of Pharmacy & Medicine